CanaQuest Medical Corp.
CANQF
$0.00
$0.000.00%
OTC PK
| 03/31/2018 | 12/31/2017 | 09/30/2017 | 06/30/2017 | 03/31/2017 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -2.29% | -73.97% | -81.91% | -95.77% | -41.24% |
| Depreciation & Amortization | -6.06% | -60.61% | 48.48% | -14.71% | -34.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.38% | -59.28% | -88.40% | -70.37% | -41.13% |
| Operating Income | -24.38% | 59.28% | 88.40% | 70.37% | 41.13% |
| Income Before Tax | -0.77% | 89.82% | 77.22% | 68.44% | 23.64% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 1.39% | 89.62% | 77.22% | 68.44% | 21.96% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.39% | 89.62% | 77.22% | 68.44% | 21.96% |
| EBIT | -24.38% | 59.28% | 88.40% | 70.37% | 41.13% |
| EBITDA | -24.61% | 59.27% | 89.65% | 71.12% | 41.18% |
| EPS Basic | 11.74% | 92.13% | 83.06% | 76.84% | 49.35% |
| Normalized Basic EPS | -17.50% | 84.31% | 83.19% | 77.06% | 59.10% |
| EPS Diluted | 11.74% | 92.13% | 83.06% | 76.84% | 49.35% |
| Normalized Diluted EPS | -17.50% | 84.31% | 83.19% | 77.06% | 59.10% |
| Average Basic Shares Outstanding | 11.59% | 32.33% | 34.15% | 37.10% | 54.00% |
| Average Diluted Shares Outstanding | 11.59% | 32.33% | 34.15% | 37.10% | 54.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |